Kelly Lawrence W & Associates’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-269,569
Closed -$10.3M 161
2025
Q1
$10.3M Sell
269,569
-2,824
-1% -$120K 2.5% 16
2024
Q4
$12M Buy
272,393
+13,100
+5% +$575K 2.79% 14
2024
Q3
$11.2M Buy
259,293
+9,268
+4% +$413K 2.52% 17
2024
Q2
$11.3M Buy
+250,025
New +$13M 2.58% 16
2018
Q1
Sell
-103,273
Closed -$7.04M 144
2017
Q4
$7.04M Hold
103,273
1.3% 30
2017
Q3
$7.4M Sell
103,273
-436
-0.4% -$30.4K 1.41% 29
2017
Q2
$7.03M Sell
103,709
-7,378
-7% -$503K 1.39% 30
2017
Q1
$7.51M Hold
111,087
1.55% 29
2016
Q4
$6.87M Buy
111,087
+4,183
+4% +$247K 1.52% 29
2016
Q3
$5.78M Buy
106,904
+116
+0.1% +$5.85K 1.24% 35
2016
Q2
$4.86M Hold
106,788
1.12% 33
2016
Q1
$5.25M Buy
+106,788
New +$4.54M 1.32% 31
2015
Q3
Sell
-148,437
Closed -$11.8M 148
2015
Q2
$11.8M Buy
+148,437
New +$12.6M 2.35% 22

Other funds holding ENOV

Kelly Lawrence W & Associates's ENOV Position: Q2 2025 in Review

Kelly Lawrence W & Associates sold out of Enovis (ENOV) in Q2 2025, closing a stake of 269,569 shares — an estimated $10.3M sold.

Kelly Lawrence W & Associates first reported a position in ENOV in Q2 2015 and held it in 13 quarters. The position peaked at $12M in Q4 2024. 285 funds tracked by Wall St. Rank hold ENOV as of Q2 2025.

  • Kelly Lawrence W & Associates reported no remaining Enovis position as of Q2 2025 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 269,569 Enovis shares in Q2 2025, an estimated $10.3M.
  • Kelly Lawrence W & Associates first reported a position in Enovis in Q2 2015 and held it in 13 quarters.
  • Kelly Lawrence W & Associates's Enovis position peaked at $12M in Q4 2024.
  • 285 funds tracked by Wall St. Rank held Enovis as of Q2 2025.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2025, filed 14 Aug 2025.